Stocks Near Their 52-Week High — Valuation View · Pharmaceutical Preparations
42 stocks match the Stocks Near Their 52-Week High screen. Stocks trading within 10% of their 52-week high — at or below it, not necessarily at a new one — largest first. Valuation columns. Filtered to Pharmaceutical Preparations. Data as of close · Checked
| LLY | Lilly (Eli) | $1.33T | 48.37 | 15.43 | 33.13 | 273.09 | 0.5% | 1418.07 | +0.62% | 192K |
| JNJ | Johnson & Johnson | $665.2B | 41.33 | 6.70 | 8.16 | 39.34 | 1.9% | 276.34 | +3.82% | 373K |
| ONC | Beone Medicines Ltd. | $558.0B | 850.93 | 91.04 | 107.84 | 109.45 | — | 377.48 | +6.36% | 40K |
| ABBV | AbbVie | $521.3B | 50.40 | 7.90 | — | 48.38 | 2.3% | 294.91 | +3.16% | 341K |
| MRK | Merck | $370.7B | 151.12 | 5.50 | 8.26 | 38.82 | 2.3% | 150.37 | +3.93% | 358K |
| PFE | Pfizer | $175.5B | 43.52 | 2.76 | 1.97 | 96.22 | 5.6% | 30.79 | +2.70% | 3.2M |
| VRTX | Vertex Pharmaceuticals | $139.2B | 35.01 | 10.75 | 6.66 | 27.96 | — | 549.07 | +3.37% | 82K |
| BMY | Bristol Myers Squibb | $131.2B | 14.20 | 2.62 | 5.61 | 13.71 | 3.9% | 64.20 | +4.04% | 482K |
| REGN | Regeneron Pharmaceuticals | $96.3B | 19.99 | 5.70 | 2.87 | 26.32 | 0.4% | 930.90 | -4.41% | 65K |
| TEVA | Teva Pharmaceutical Industries Ltd | $48.8B | 96.39 | 2.83 | 6.11 | 11.94 | — | 41.80 | -0.24% | 577K |
| RPRX | Royalty Pharma Plc | $30.1B | 44.80 | 11.50 | 3.07 | 58.56 | 1.4% | 67.56 | +1.82% | 202K |
| UTHR | United Therapeutics Corp | $25.9B | 21.02 | 8.12 | 4.12 | 21.76 | — | 607.43 | +0.95% | 68K |
| VTRS | Viatris | $22.1B | -6.29 | 1.50 | 1.55 | 24.93 | 2.5% | 19.25 | +1.61% | 631K |
| ELAN | Elanco Animal Health Inc | $12.6B | -63.54 | 2.52 | 1.92 | 23.86 | — | 25.31 | +2.97% | 920K |
| TGTX | Tg Therapeutics, Inc. | $9.4B | 21.39 | 11.81 | 15.63 | 19.56 | — | 61.68 | +1.49% | 76K |
| SYRE | Spyre Therapeutics, Inc. | $9.4B | -35.70 | — | 8.96 | 113.87 | — | 99.19 | -0.14% | 108K |
| KNSA | Kiniksa Pharmaceuticals International, Plc | $7.5B | 68.11 | 7.89 | 10.51 | 91.39 | — | 96.08 | +3.15% | 44K |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.4B | 40.53 | 2.05 | 193.12 | 49.97 | — | 19.97 | -1.29% | 237K |
| LGND | Ligand Pharmaceuticals Inc | $6.3B | 122.89 | 24.92 | 6.58 | 113.02 | — | 316.17 | +0.69% | 9K |
| ARQT | Arcutis Biotherapeutics, Inc. | $4.3B | 144.72 | 8.51 | 17.74 | 129.70 | — | 34.23 | +6.90% | 194K |
| OGN | Organon & Co. | $3.6B | 17.09 | 0.60 | 3.05 | 2.50 | 0.6% | 13.86 | +0.11% | 189K |
| BHC | Bausch Health Companies Inc. | $3.1B | -3.71 | 0.28 | — | 1.26 | — | 8.34 | +2.58% | 253K |
| SLN | Silence Therapeutics Plc | $2.8B | -46.79 | 4561.03 | 72.91 | 38.93 | — | 19.79 | +0.00% | 70K |
| XNCR | Xencor Inc | $2.6B | -22.30 | 13.11 | 4.69 | 44.09 | — | 35.03 | +14.33% | 113K |
| PVLA | Palvella Therapeutics, Inc. | $2.3B | -37.99 | — | 10.81 | 12.48 | — | 162.66 | +6.31% | 34K |
| SEPN | Septerna, Inc. | $2.2B | -92.21 | 22.60 | 5.78 | 26.40 | — | 47.88 | +9.47% | 57K |
| ZYME | Zymeworks Inc. | $2.2B | -14.64 | 20.72 | 27.32 | 12.24 | — | 30.94 | +2.69% | 40K |
| XERS | Xeris Biopharma Holdings, Inc. | $1.9B | -111.10 | 5.69 | — | 15.66 | — | 10.46 | +0.97% | 234K |
| PCRX | Pacira Biosciences, Inc. | $1.5B | 99.19 | 1.95 | 2.16 | 7.05 | — | 36.42 | +0.10% | 165K |
| OPK | OPKO HEALTH, INC. | $1.3B | -8.98 | 2.65 | 1.19 | 3.46 | — | 1.79 | +3.47% | 218K |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.2B | 15.19 | 1.63 | 1.55 | 5.33 | — | 28.04 | +3.35% | 31K |
| RIGL | Rigel Pharmaceuticals Inc | $958M | 2.98 | — | 2.25 | 15.76 | — | 51.30 | +4.87% | 12K |
| VSTM | Verastem, Inc. | $894M | -4.41 | — | 17.88 | 6.56 | — | 9.87 | +0.87% | 240K |
| DMAC | DiaMedica Therapeutics Inc. | $582M | -15.50 | — | 15.18 | 113.44 | — | 10.79 | +7.68% | 30K |
| PBYI | PUMA BIOTECHNOLOGY, INC. | $553M | 20.69 | 2.39 | 3.99 | 15.13 | — | 10.71 | +4.59% | 29K |
| RLYB | Rallybio Corp | $86M | 3.19 | 197.25 | 0.93 | 0.94 | — | 15.90 | +0.16% | 919 |
| GMAB | Genmab A/S | — | — | — | — | — | — | 55.08 | -0.74% | 328K |
| RDY | Dr Reddys Laboratories Ltd | — | — | — | — | — | — | 14.77 | +3.18% | 248K |
| TAK | Takeda Pharmaceutical Co Ltd | — | — | — | — | — | — | 21.07 | +1.47% | 205K |
| ASND | Ascendis Pharma A/S | — | — | — | — | — | — | 257.95 | +3.22% | 40K |
| SNY | Sanofi | — | — | — | — | — | — | 47.44 | +4.65% | 446K |
| NVS | Novartis Ag | — | — | — | — | — | — | 165.02 | +3.64% | 116K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.